COVID-19 Vaccines

Eligibility for children 6 months to under 5 years of age

COVID-19 vaccine is available for children six months to under five years of age.

• If the child has been ill with COVID-19, we recommend waiting two months (56 days) to allow for the best immune response before receiving their first or second dose. 
• Moderna COVID-19 vaccine for those six months to five years of age is a two-dose series. The National Advisory Committee on Immunization (NACI) recommends an interval of eight weeks between first and second dose to provide the strongest possible protection against COVID-19. With informed consent, the minimum interval is 28 days.
• For those who are six months to five years of age, and immunocompromised or have a history of MIS-C, please review the provincial vaccine recommendations.

Receiving other vaccines before and after COVID-19 vaccine

Children between six months and under five years should wait 14 days before or after the administration of another vaccine before getting their COVID-19 vaccine. Parents and caregivers of children aged six months to under five years should discuss COVID-19 vaccination with their health care provider to determine the best timing and approach for COVID-19 vaccination. A shorter interval between the administration of Moderna vaccine and a different vaccine may be warranted in some circumstances at the discretion of your child’s health care provider. 

Learn about the COVID-19 vaccine for children under five years of age and the benefits of getting the vaccine for this age group.

Second booster dose eligibility for those 12 to 17 years of age and immunocompromised

• Individuals 12 years of age or older who are moderately to severely immunocompromised should get a second booster (fifth dose) six months (168 days) after their first booster (or a minimum of three months or 84 days). 
• For individuals who have been ill with COVID-19, we recommend waiting 3 months (84 days) to allow for the best immune response before receiving their second booster dose.

Booking information for first and second doses

• Individuals who received an mRNA (Pfizer or Moderna) vaccine as a first dose should wait 56 days before receiving a second dose.

Fourth dose eligibility

• Fourth doses are available for those 18 years of age and older who received their third dose a minimum of 84 days ago. The province of Ontario recommends a 5 month (140 days) wait time between third and fourth dose.
• If you have been ill with COVID-19, we recommend waiting 3 months (84 days) to allow for the best immune response before receiving your third or fourth booster.
• High-risk individuals who should get their second booster dose as soon as possible and many of whom have been eligible to do so for months include:
  • Individuals aged 60 and over;
  • First Nation, Inuit and Métis individuals and their non-Indigenous household members aged 18 and over;
  • Residents of a long-term care home, retirement home, or Elder Care Lodge and older adults living in other congregate settings that provide assisted-living and health services; and
  • Individuals who are moderately to severely immunocompromised.

Second booster dose for specific populations

• Fifth doses (second booster doses) are now available for moderate-to-severely immunocompromised individuals 18 years of age or older who received their fourth dose (first booster dose) a minimum of 84 days ago. The Ontario Ministry of Health recommends a five month (140 days) wait time between first and second booster doses. 

 Third dose eligibility

• Third doses are available for those 12 to 17 who received their second dose at least 168 days ago, and for adults 18 years of age and older who have received their second dose 84 days ago. 
• An mRNA vaccine, Moderna or Pfizer, is recommended as the third dose unless an individual has an allergy to a component of the vaccine or has a history of a severe reaction to their first or second dose of mRNA vaccine. 

Janssen vaccine

• Due to the approval and availability of a safer and more effective product, Novovax Nuvaxovid Covid-19 vaccine, we no longer are providing the Janssen vaccine.
• If you have concerns about mRNA vaccine and would prefer to receive the Novavax Nuvaxovid Covid-19 vaccine, phone our COVID-19 call centre at 613-549-1232 to be added to a wait list.

Nuvaxovid vaccine

• Health Canada has approved the Novavax Nuvaxovid COVID-19 vaccine as of February 17 and the National Advisory Committee on Immunization (NACI) has issued recommendations for its use.

• The Novavax Nuvaxovid COVID-19 vaccine is available as:

  • A first and second dose primary series

  • A first, second, and third dose primary series for those who are immunocompromised, with informed consent.

• The Novavax Nuvaxovid COVID-19 vaccine is not currently authorized for use as a booster dose (third or fourth dose) in Canada.

• If you have concerns about mRNA vaccine and would prefer to receive Novavax vaccine, phone our COVID-19 call centre at 613-549-1232 to be added to a wait list.

Medicago vaccine

• On February 24, Health Canada approved the Medicago COVID-19 vaccine for adults aged 18 to 64.
• KFL&A Public Health is waiting to receive further guidance from the National Advisory Committee on Immunization and supply details from the federal government.